{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T09:10:11Z","timestamp":1759050611496,"version":"3.44.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,19]],"date-time":"2023-08-19T00:00:00Z","timestamp":1692403200000},"content-version":"am","delay-in-days":322,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP20H03592"],"award-info":[{"award-number":["JP20H03592"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.jneuroim.2022.577950","type":"journal-article","created":{"date-parts":[[2022,8,11]],"date-time":"2022-08-11T22:28:45Z","timestamp":1660256925000},"page":"577950","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Immunodeficiency in patients with thymoma-associated myasthenia gravis"],"prefix":"10.1016","volume":"371","author":[{"given":"Kei","family":"Ishizuchi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsubasa","family":"Takizawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuko","family":"Ohnuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Sekiguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haruhiko","family":"Motegi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Munenori","family":"Oyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin","family":"Nakahara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Shiina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeaki","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2022.577950_bb0005","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1093\/cid\/ciu646","article-title":"Prevention of infections during primary immunodeficiency","volume":"59","author":"Aguilar","year":"2014","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jneuroim.2022.577950_bb0010","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1111\/ene.14820","article-title":"Clinical characteristics and outcomes of thymoma-associated myasthenia gravis","volume":"28","author":"Alvarez-Velasco","year":"2021","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.jneuroim.2022.577950_bb0015","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.autrev.2015.09.005","article-title":"Thymoma associated with autoimmune diseases: 85 cases and literature review","volume":"15","author":"Bernard","year":"2016","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jneuroim.2022.577950_bb0020","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/ana.1017","article-title":"Mature, long-lived CD4+ and CD8+ T cells are generated by the thymoma in myasthenia gravis","volume":"50","author":"Buckley","year":"2001","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2022.577950_bb0025","article-title":"Severe COVID-19 pneumonia in Good syndrome with a favorable outcome","volume":"108789","author":"Cos Esquius","year":"2021","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.jneuroim.2022.577950_bb0030","article-title":"A case of severe COVID-19 in a patient with Good's syndrome","volume":"8","author":"Duarte","year":"2021","journal-title":"Eur. J. Case Rep. Intern. Med."},{"key":"10.1016\/j.jneuroim.2022.577950_bb0035","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1111\/j.1365-2249.2005.02951.x","article-title":"Common variable immunodeficiency and the complement system; low mannose-binding lectin levels are associated with bronchiectasis","volume":"142","author":"Fevang","year":"2005","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jneuroim.2022.577950_bb0040","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.semarthrit.2008.05.002","article-title":"Serum immunoglobulins and risk of infection: how low can you go?","volume":"39","author":"Furst","year":"2009","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.jneuroim.2022.577950_bb0045","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S1474-4422(15)00145-3","article-title":"Myasthenia gravis: subgroup classification and therapeutic strategies","volume":"14","author":"Gilhus","year":"2015","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jneuroim.2022.577950_bb0050","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1007\/s00415-018-8751-9","article-title":"Myasthenia gravis and infectious disease","volume":"265","author":"Gilhus","year":"2018","journal-title":"J. Neurol."},{"key":"10.1016\/j.jneuroim.2022.577950_bb0055","first-page":"1","article-title":"Agammaglobulinemia: a provocative experiment of nature","volume":"26","author":"Good","year":"1954","journal-title":"Bull. Univ. Minnesota Hosp. Minn. Med. Found."},{"key":"10.1016\/j.jneuroim.2022.577950_bb0060","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/S1474-4422(21)00159-9","article-title":"Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial","volume":"20","author":"Howard","year":"2021","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jneuroim.2022.577950_bb0065","doi-asserted-by":"crossref","first-page":"3418","DOI":"10.1111\/ene.14951","article-title":"Predictive factors for a severe course of COVID-19 infection in myasthenia gravis patients with an overall impact on myasthenic outcome status and survival","volume":"28","author":"Jakubikova","year":"2021","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.jneuroim.2022.577950_bb0070","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1212\/WNL.55.1.16","article-title":"Myasthenia gravis: recommendations for clinical research standards. Task force of the medical scientific advisory board of the Myasthenia Gravis Foundation of America","volume":"55","author":"Jaretzki","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2022.577950_bb0075","doi-asserted-by":"crossref","first-page":"102","DOI":"10.2177\/jsci.29.102","article-title":"A case of Good syndrome accompanied by myasthenia gravis: immunological evaluations","volume":"29","author":"Katsuki","year":"2006","journal-title":"Nihon Rinsho Meneki Gakkai Kaishi"},{"key":"10.1016\/j.jneuroim.2022.577950_bb0080","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.clim.2010.01.006","article-title":"Good\u2019s syndrome remains a mystery after 55 years: a systematic review of the scientific evidence","volume":"135","author":"Kelesidis","year":"2010","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.jneuroim.2022.577950_bb0085","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1084\/jem.20091669","article-title":"Chronic mucocutaneous candidiasis in APECED or thymoma patients correlates with autoimmunity to Th17-associated cytokines","volume":"207","author":"Kisand","year":"2010","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jneuroim.2022.577950_bb0090","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1002\/eji.201041253","article-title":"Mucocutaneous candidiasis and autoimmunity against cytokines in APECED and thymoma patients: clinical and pathogenetic implications","volume":"41","author":"Kisand","year":"2011","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jneuroim.2022.577950_bb0095","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/1759-7714.13000","article-title":"Thymic neoplasms patients complicated with bronchiectasis: case series in a Chinese hospital and literature review","volume":"10","author":"Liu","year":"2019","journal-title":"Thorac. Cancer"},{"key":"10.1016\/j.jneuroim.2022.577950_bb0100","article-title":"Minor clinical impact of COVID-19 pandemic on patients with primary immunodeficiency in Israel","volume":"11","author":"Marcus","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jneuroim.2022.577950_bb0105","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1002\/1097-0142(19811201)48:11<2485::AID-CNCR2820481123>3.0.CO;2-R","article-title":"Follow-up study of thymomas with special reference to their clinical stages","volume":"48","author":"Masaoka","year":"1981","journal-title":"Cancer"},{"key":"10.1016\/j.jneuroim.2022.577950_bb0110","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/QCO.0000000000000473","article-title":"Prevention of infectious diseases in patients with Good syndrome","volume":"31","author":"Multani","year":"2018","journal-title":"Curr. Opin. Infect. Dis."},{"key":"10.1016\/j.jneuroim.2022.577950_bb0115","article-title":"Thymoma-associated T-cell immunodeficiency after radiotherapy: a case report","volume":"33","author":"Nakagawara","year":"2021","journal-title":"Respir. Med. Case Rep."},{"key":"10.1016\/j.jneuroim.2022.577950_bb0120","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1684\/ejd.2017.2993","article-title":"GVHD-like erythroderma in the clinical course of thymoma-associated myasthenia gravis","volume":"27","author":"Nomura","year":"2017","journal-title":"Eur. J. Dermatol."},{"key":"10.1016\/j.jneuroim.2022.577950_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2020.108644","article-title":"Fatal SARS-CoV-2 infection in a male patient with Good\u2019s syndrome","volume":"223","author":"Pozzi","year":"2021","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.jneuroim.2022.577950_bb0130","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1002\/path.2141","article-title":"Deficiency of the autoimmune regulator AIRE in thymomas is insufficient to elicit autoimmune polyendocrinopathy syndrome type 1 (APS-1)","volume":"211","author":"Strobel","year":"2007","journal-title":"J. Pathol."},{"key":"10.1016\/j.jneuroim.2022.577950_bb0135","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1111\/j.1468-1331.2005.01002.x","article-title":"Myasthenia gravis accompanied by alopecia areata: clinical and immunogenetic aspects","volume":"12","author":"Suzuki","year":"2005","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.jneuroim.2022.577950_bb0140","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jneuroim.2010.10.023","article-title":"Clinical and immunological differences between early and late-onset myasthenia gravis in Japan","volume":"230","author":"Suzuki","year":"2011","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2022.577950_bb0145","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1136\/jnnp-2012-304057","article-title":"Overlooked non-motor symptoms in myasthenia gravis","volume":"84","author":"Suzuki","year":"2013","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jneuroim.2022.577950_bb0150","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/ene.12234","article-title":"Cardiac involvements in myasthenia gravis associated with anti-Kv1.4 antibodies","volume":"21","author":"Suzuki","year":"2014","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.jneuroim.2022.577950_bb0155","series-title":"WHO Classification of Tumours of the Lung, Pleura, thymus and Heart","first-page":"183","author":"Travis","year":"2015"},{"key":"10.1016\/j.jneuroim.2022.577950_bb0160","doi-asserted-by":"crossref","first-page":"3880","DOI":"10.4049\/jimmunol.1401068","article-title":"Clinical and serologic parallels to APS-I in patients with thymomas and autoantigen transcripts in their tumors","volume":"193","author":"Wolff","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2022.577950_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2019.102349","article-title":"HLA in myasthenia gravis: from superficial correlation to underlying mechanism","volume":"18","author":"Zhong","year":"2019","journal-title":"Autoimmun. Rev."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016557282200145X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016557282200145X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:41:57Z","timestamp":1759048917000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016557282200145X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":33,"alternative-id":["S016557282200145X"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2022.577950","relation":{},"ISSN":["0165-5728"],"issn-type":[{"type":"print","value":"0165-5728"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunodeficiency in patients with thymoma-associated myasthenia gravis","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2022.577950","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"577950"}}